This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Nygren, E.
Right arrow Articles by Attridge, S. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nygren, E.
Right arrow Articles by Attridge, S. R.

 Previous Article  |  Next Article 

Infection and Immunity, August 2009, p. 3475-3484, Vol. 77, No. 8
0019-9567/09/$08.00+0     doi:10.1128/IAI.01197-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Establishment of an Adult Mouse Model for Direct Evaluation of the Efficacy of Vaccines against Vibrio cholerae{triangledown}

E. Nygren, B.-L. Li, J. Holmgren, and S. R. Attridge*

Department of Microbiology and Immunology and University of Gothenburg Vaccine Research Institute, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden

Received 26 September 2008/ Returned for modification 20 December 2008/ Accepted 15 May 2009

We describe here a new animal model that offers the prospect of using conventional adult mice for direct evaluation of the protective potential of new cholera vaccines. Pretreatment of adult mice with oral streptomycin allowed intestinal colonization by streptomycin-resistant Vibrio cholerae strains of either the O1 or the O139 serogroup. Bacteria were recovered in greatest numbers from the cecum and large intestine, but recoveries from all regions of the gut correlated significantly with bacterial excretion in fresh fecal pellets, which thus provides a convenient indicator of the extent and duration of gut colonization. Mice immunized mucosally or systemically with viable or inactivated V. cholerae were shown to be comparatively refractory to colonization after challenge with the immunizing strain. Several variables were examined to optimize the model, the most significant being the size of the challenge inoculum; surprisingly, a smaller challenge dose resulted in more consistent and sustained colonization. Studies with mutant strains unable to produce cholera toxin or toxin-coregulated pili revealed that neither factor contributed significantly to colonization potential. Protection against V. cholerae challenge was shown to be serogroup restricted, and significant inverse correlations were detected between serum and intestinal anti-lipopolysaccharide antibody responses and the levels of excretion of challenge organisms.

* Corresponding author. Mailing address: Department of Microbiology and Immunology, Sahlgrenska Academy at Gothenburg University, P.O. Box 435, SE-405 30, Gothenburg, Sweden. Phone: 46 31 786 6239. Fax: 46 31 786 6210. E-mail: stephen.attridge{at}microbio.gu.se

{triangledown} Published ahead of print on 26 May 2009.

Editor: V. J. DiRita

Infection and Immunity, August 2009, p. 3475-3484, Vol. 77, No. 8
0019-9567/09/$08.00+0     doi:10.1128/IAI.01197-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»